In the early phases of ulcerative colitis (UC)–associated colon carcinogenesis, it is thought that the p53 gene mutation plays a significant role, and the expression of proteins of p53 in UC-associated colon cancers may be a useful biomarker [55]. This evidence concerns the gene TP53 and digestive system cancer.